Your browser doesn't support javascript.
loading
Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy.
Muckenhuber, Moritz; Mucha, Jasmin; Mengrelis, Konstantinos; How, Christopher; Reindl-Schwaighofer, Roman; Heinzel, Andreas; Kainz, Verena; Worel, Nina; Berlakovich, Gabriela; Edinger, Matthias; Oberbauer, Rainer; Wekerle, Thomas.
Afiliación
  • Muckenhuber M; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • Mucha J; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • Mengrelis K; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • How C; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • Reindl-Schwaighofer R; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Heinzel A; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kainz V; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
  • Berlakovich G; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
  • Edinger M; Leibniz Institute of Immunotherapy, Regensburg, Germany; Department of Internal Medicine 3 (Hematology and Oncology), University Hospital Regensburg, Regensburg, Germany.
  • Oberbauer R; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Wekerle T; Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.wekerle@meduniwien.ac.at.
Am J Transplant ; 23(1): 84-92, 2023 01.
Article en En | MEDLINE | ID: mdl-36695625

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Suero Antilinfocítico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Suero Antilinfocítico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Austria